Identification of western equine encephalitis virus structural proteins that confer protection after DNA vaccination

Clinical and Vaccine Immunology

Volumn 17, Issue 1, 2010, Pages 176-179

  Gauci, Penelope J ^a   Wu, Josh Q H ^b   Rayner, George A ^b   Barabé, Nicole D ^b   Nagata, Leslie P ^b   Proll, David F ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; STRUCTURAL PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; ENCEPHALITIS; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS STRAIN; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ANIMALS; ANTIGENS, VIRAL; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, WESTERN EQUINE; ENCEPHALOMYELITIS, EQUINE; FEMALE; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS; VACCINES, DNA; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 74549175318     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00377-09     Document Type: Article

References (14)

1. Das, D., S. L. Gares, L. P. Nagata, and M. R. Suresh. 2004. Evaluation of a western equine encephalitis recombinant E1 protein for protective immunity and diagnostics. Antivir. Res. 64:85-92.
2. Doria-Rose, N. A., and N. L. Haigwood. 2003. DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31:207-216.
3. Garmashova, N., S. Atasheva, W. Kang, S. C. Weaver, E. Frolova, and I. Frolov. 2007. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J. Virol. 81:13552-13565.
4. Griffin, D. E. 2007. Alphaviruses, p. 1023-1067. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 1, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
5. Hodgson, L. A., G. V. Ludwig, and J. F. Smith. 1999. Expression, processing, and immunogenicity of the structural proteins of Venezuelan equine encephalitis virus from recombinant baculovirus vectors. Vaccine 17:1151-1160.
6. Lasaro, M. O., and H. C. Ertl. 2009. New insights on adenovirus as vaccine vectors. Mol. Ther. 17:1333-1339.
7. Logue, C. H., C. F. Bosio, T. Welte, K. M. Keene, J. P. Ledermann, A. Phillips, B. J. Sheahan, D. J. Pierro, N. Marlenee, A. C. Brault, C. M. Bosio, A. J. Singh, A. M. Powers, and K. E. Olson. 2009. Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. J. Gen. Virol. 90:1848-1858.
8. Long, M. C., L. P. Nagata, G. V. Ludwig, A. Z. Alvi, J. D. Conley, A. R. Bhatti, M. R. Suresh, and R. E. Fulton. 2000. Construction and characterization of monoclonal antibodies against western equine encephalitis virus. Hybridoma 19:121-127.
9. Nagata, L. P., W. G. Hu, S. A. Masri, G. A. Rayner, F. L. Schmaltz, D. Das, J. Wu, M. C. Long, C. Chan, D. Proll, S. Jager, L. Jebailey, M. R. Suresh, and J. P. Wong. 2005. Efficacy of DNA vaccination against western equine encephalitis virus infection. Vaccine 23:2280-2283.
10. Nagata, L. P., W. G. Hu, M. Parker, D. Chau, G. A. Rayner, F. L. Schmaltz, and J. P. Wong. 2006. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. J. Gen. Virol. 87:2353-2361.
11. Netolitzky, D. J., F. L. Schmaltz, M. D. Parker, G. A. Rayner, G. R. Fisher, D. W. Trent, D. E. Bader, and L. P. Nagata. 2000. Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes. J. Gen. Virol. 81:151-159.
12. Perkins, S. D., L. M. O'Brien, and R. J. Phillpotts. 2006. Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination. Vaccine 24:3440-3445.
13. Phillpotts, R. J., L. O'Brien, R. E. Appleton, S. Carr, and A. Bennett. 2005. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus. Vaccine 23:1615-1623.
14. Richard, J. K. 2007. Togaviridae: the viruses and their replication, p. 1000-1022. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 1, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.